Clinical Trial Update: Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D [Phase 3]

View source ↗

Summary

Phase 3 trial update for ferric citrate in transitioning from CKD stages 4/5 to 5D; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia
• Iron Deficiency Anemia
• Renal Insufficiency

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Denver Nephrologists, P.C. | Conditions: Chronic Kidney Disease, Hyperphosphatemia | Phase 3 | Status: COMPLETED